药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aminorex
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Entrectinib.
Aminorex
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Entrectinib.
Aminorex
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Entrectinib.
Aminorex
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Entrectinib.
Aminorex
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Entrectinib.
Aminorex
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Entrectinib.
Aminorex
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Entrectinib.
Aminorex
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Entrectinib.
Aminorex
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Entrectinib.
Aminorex
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Entrectinib.
Aminorex
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Deutetrabenazine is combined with Entrectinib.
Aminorex
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Entrectinib.
Aminorex
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Entrectinib.
Aminorex
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Entrectinib.
Aminorex
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Entrectinib.
Aminorex
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Entrectinib.
Aminorex
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Entrectinib.
Aminorex
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Entrectinib.
Aminorex
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Entrectinib.
Aminorex
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Entrectinib.